For example, our algorithm identified ERBB2 for ERBB2-positive breast cancer [54], VEGF for renal cell carcinoma [55], and MS4A1 (CD20) for non-Hodgkin's lymphoma [56]. Here, ERBB2 is linked to non-Hodgkin lymphoma.